
In a technologically advanced health care landscape, solutions to address language barriers are necessary and can be the difference between life and death for complex medication regimens.

In a technologically advanced health care landscape, solutions to address language barriers are necessary and can be the difference between life and death for complex medication regimens.

Sharon Blank, CEO of RxTran and Language Scientific, discusses language hurdles in the safe delivery of medications for patients and pharmacists alike.

As the pharmacist’s role continues to expand throughout health care, they are now being challenged to step in as opioid stewards in a rapidly evolving pain management landscape.

In part 2, Richard Dion, PharmD, addresses some of the persistent challenges among hospital pharmacies and their pain management models, offering some expert solutions to move forward.

In part 2, Paul Licciardi, PhD, dives into the evolving need for updated pneumococcal vaccine recommendations and how pharmacists can keep their patients informed.

Richard Dion, PharmD, joins to discuss the growing prominence of opioid stewardship and where the pharmacist can assist in patient programming.

In part 1 of our interview with Paul Licciardi, PhD, he addresses the lowered pneumococcal vaccination age as well as the adult population’s overall relationship with immunization.

Pharmacist credentialing unlocks payer contracts and boosts reimbursement and can help avoid risky third-party billing as clinical services expand.

With GLP-1 questions creating confusion for Medicare patients, pharmacists are becoming the trusted frontline resource, and the stakes for getting it right have never been higher.

Often operating in the shadows, LTC pharmacy is the backbone of medication management for aging and immunocompromised patients.

In-home pharmacist visits uncover medication risks, improve adherence and deprescribing, and help older adults stay safer at home.

In part 2 of our interview, Esmé Grewal, JD, discusses the key opportunities LTC pharmacies possess in assisting the aging population in medication management.

In part 2 of our interview series with Lisa Lavin, she explored the capabilities of her company’s Home Health Hub and how it’s transforming health care access for rural populations.

Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.

Tarah Davis, PharmD, MBA, AFMC, discusses the superpower of personalized patient roadmaps and how identifying drug-induced nutrient depletions is the key to resolving digestive dysfunction.

In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.

Community pharmacies redesign workflows to address insurance barriers and deliver safer, gender-affirming care.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

AI reshapes everyday tasks in the community pharmacy from refill automation to documentation.

The Age-Friendly Pharmacy certification and the 4Ms reshape senior care, teamwork, and deprescribing by putting the patient in the center of care.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.

Pharmacies can build clinical workflows, bill like providers, and get paid for MTM and test-and-treat services patients value.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.

An open line of communication between care teams is key to improving patient outcomes.

Controlling symptoms of allergy and asthma helps patients improve quality of life.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

Declining Black-owned pharmacies reshape community care, and pharmacists can advance health equity today.

From PBM reform designed to benefit pharmacies to closures impacting the greater public health sector, Tom DePietro, PharmD, discusses current developments in community pharmacy.